Prospects for Skin Cancer Treatment and Prevention: The Potential Contribution of an Engineered Virus

Autor: Jennifer A. Cafardi, Mohammad Athar, Craig A. Elmets, Rubina Shafi
Rok vydání: 2011
Předmět:
Zdroj: Journal of Investigative Dermatology. 131(3):559-561
ISSN: 0022-202X
DOI: 10.1038/jid.2010.394
Popis: Nonmelanoma skin cancers, which include basal cell and squamous cell carcinomas, are among the most common human malignancies. Although they are typically not lethal, they are responsible for tissue deformity and substantial morbidity in humans, particularly in high risk populations such as organ transplant recipients. Solar UVB, which is a major etiologic factor for this kind of malignancy, produces DNA lesions that include cyclobutane pyrimidine dimers (CPD) and 6–4 photoproducts in the skin. Human cells remove these lesions through nucleotide excision repair. Humans lack a DNA glycosylase required to initiate base excision repair of pyrimidine-pyrimidine photoproducts but produce all of the other proteins required for this form of DNA repair process. In this issue of the Journal of Investigative Dermatology, Johnson et al show that a DNA glycosylase derived from Chlorella virus and engineered to enhance tissue penetration and nuclear localization, can effectively remove these UVB-induced DNA lesions in a human skin equivalent model and the protein can be incorporated into a topical formulation for the prevention and treatment of UVB-induced DNA damage. These studies are highly pertinent and suggest that such an enzyme may be eventually incorporated into regimens for the chemoprevention of skin cancers.
Databáze: OpenAIRE